Triptorelin
ResearchA GnRH agonist that initially stimulates and then suppresses testosterone production. Used clinically for prostate cancer and researched for post-cycle testosterone restoration.
Reproductive HealthHormonal Health
Half Life
~3 hours (short form) to months (depot)
Time to Results
Weeks
Administration
SubQ injection, Intramuscular

๐พ Griffin's Research Scorecard
Research Strength
Human Data
Animal Data
Long-Term Data
Beginner Friendly
Storage Difficulty
Injection FrequencySingle dose or very infrequent
Cost$$$

๐พ Griffin Says...
Triptorelin is researched as a one-time pituitary restart after testosterone suppression. A single low dose can kick-start the HPTA axis. This is advanced hormonal research territory. Repeated use suppresses, single use stimulates - context matters enormously here.
Benefits
- Testosterone axis restart research
- Post-cycle recovery
- Hormonal regulation research
Best For
- Advanced hormonal research
- Post-cycle research
Body Systems
ReproductiveEndocrine
Mechanisms of Action
- GnRH agonist - initially stimulates, then desensitizes pituitary
- Single pulse can restart HPTA axis
- Sustained use suppresses testosterone
Side Effects
| Effect | Frequency | Severity |
|---|---|---|
| Hot flashes | Common | Mild |
| Temporary testosterone suppression | With repeated use | Serious |
Contraindications
Do not use repeatedly - will suppress testosterone, not approved for general use
Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.
Ready to calculate your dose? Use Griffin's Peptide Calculator ๐พ
Open Calculator